Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,409 | -25,499 | -18,729 | -14,578 | -7,174 |
| Depreciation Amortization | 855 | 1,015 | 901 | 294 | 214 |
| Accounts receivable | 3 | -55 | -22 | -110 | 1 |
| Accounts payable and accrued liabilities | 89 | -223 | -199 | 53 | -347 |
| Other Working Capital | -157 | -1,767 | -1,355 | 155 | -33 |
| Other Operating Activity | -280 | 3,922 | 2,164 | 2,978 | 1,718 |
| Operating Cash Flow | $-6,898 | $-22,606 | $-17,241 | $-11,208 | $-5,621 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -39 | -37 | -37 | -19 |
| Investing Cash Flow | $-12 | $-39 | $-37 | $-37 | $-19 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 11,000 | 1,500 | N/A | 0 | N/A |
| Common Stock Issued | N/A | 22,652 | 22,652 | 6,652 | 6,652 |
| Other Financing Activity | -864 | -5,199 | -4,732 | -2,228 | -1,200 |
| Financing Cash Flow | $10,136 | $18,953 | $17,920 | $4,424 | $5,452 |
| Beginning Cash Position | 7,927 | 11,619 | 11,619 | 11,619 | 11,619 |
| End Cash Position | 11,154 | 7,927 | 12,261 | 4,799 | 11,432 |
| Net Cash Flow | $3,226 | $-3,692 | $642 | $-6,820 | $-187 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,898 | -22,606 | -17,241 | -11,208 | -5,621 |
| Capital Expenditure | -12 | -39 | -37 | -37 | -19 |
| Free Cash Flow | -6,910 | -22,645 | -17,278 | -11,245 | -5,639 |